New Novartis CDO Bodson Outlines Digital Health Ambitions
Joining the Novartis executive committee at the start of this week, newly appointed chief digital officer Bertrand Bodson reveals to Scrip how he sees digital health underpinninig the Swiss major’s future. Efforts at the company have already delivered a 10-15% reduction in patient enrolment times in pilot trials.
You may also be interested in...
Data science and data analytics offer operational advantages throughout large organizations. And the pharma should approach digital technology pragmatically, first applying the tools to what it already does.
Cambridge, UK-based Healx has concluded a $56m series B round, led by Atomico, to put up to 50 potential rare disease treatments into the clinic within two years using its AI/ML platform.
Tapping into the ability of arenaviruses to deliver prolonged local immune activation, rapid regression of localized and metastatic cancers, and long-term disease control, Essen, Germany-based start-up Abalos Therapeutics has raised €12m to advance its lead candidates towards clinical testing.